Last updated on July 2018

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma


Brief description of study

The purpose of the trial is to evaluate the efficacy and safety of two different doses of QVM149 (QVM149 150/50/80 g and QVM149 150/50/160 g via Concept1) over two respective QMF149 doses (QMF149 150/160 g and QMF149 150/320 g via Concept1 in poorly controlled asthmatics as determined by pulmonary function testing and effects on asthma control.

Clinical Study Identifier: NCT02571777

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Kamenz, Germany
4.34miles
  Connect »